August 20, 2015
Pharmaceutical company Akorn Inc. was slammed Wednesday in Illinois federal court with another derivative suit over errors the company allegedly made integrating two major acquisitions into its accounting system, this time also claiming company executives made millions of dollars selling off inflated shares.